Paris-based Innovafeed has raised €51 million as the insect-ingredients producer enters a new phase centered on commercial deployment after completing its industrialization phase.
The funding, announced on June 5, 2026, was backed largely by the company’s financial partners and supported by existing shareholders including Creadev, QIA, Temasek, FFC, ABC Impact, and ADM, alongside banking partners. The round was not further specified.
Innovafeed produces insect-based ingredients derived from Hermetia illucens for animal nutrition, pet food, and agriculture. The company said the new capital will be used to accelerate the commercial development of its Hilucia ranges, especially in aquaculture and pet food, while also funding industrial equipment, new applications, and production line upgrades aimed at improving capacity and performance.
The announcement also signals an operational shift. Innovafeed said it is reorganizing activities around its Nesle site and reducing zootechnical R&D as it pivots from industrial buildout toward commercialization.
The funding, announced on June 5, 2026, was backed largely by the company’s financial partners and supported by existing shareholders including Creadev, QIA, Temasek, FFC, ABC Impact, and ADM, alongside banking partners. The round was not further specified.
Innovafeed produces insect-based ingredients derived from Hermetia illucens for animal nutrition, pet food, and agriculture. The company said the new capital will be used to accelerate the commercial development of its Hilucia ranges, especially in aquaculture and pet food, while also funding industrial equipment, new applications, and production line upgrades aimed at improving capacity and performance.
The announcement also signals an operational shift. Innovafeed said it is reorganizing activities around its Nesle site and reducing zootechnical R&D as it pivots from industrial buildout toward commercialization.